Sector ratings Charles River Laboratories International, Inc. Deutsche Boerse AG

Stocks

Real-time Estimate Tradegate Other stock markets 01:36:50 04/07/2026 HKT			5-day change	1st Jan Change
202.45 ^EUR	+1.12%		+8.36%	+17.25%

07-02	Charles River Laboratories International Insider Sold Shares Worth $16,875,000, According to a Recent SEC Filing	MT
07-01	Argus Raises Price Target on Charles River Laboratories International to $250 From $200, Maintains Buy Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
LONZA GROUP AG	49.15B		AAA
REVOLUTION MEDICINES, INC.	40.23B	-	B	-	-
IQVIA HOLDINGS INC.	34.55B		AAA
BEONE MEDICINES AG	33.09B		-
CELLTRION, INC.	25.19B		A
ASCENDIS PHARMA A/S	17.05B	-	-	-	-
MEDPACE HOLDINGS, INC.	15.92B		BBB
EUROFINS SCIENTIFIC SE	13.83B		AA
ICON PUBLIC LIMITED COMPANY	13.26B		AAA
IONIS PHARMACEUTICALS, INC.	13.52B	-	A	-	-
BIO-TECHNE CORPORATION	11.04B		AA
TEMPUS AI, INC.	10.82B		A		-
ABIVAX	11.66B	-	BBB	-	-
APOGEE THERAPEUTICS, INC.	9.96B	-	B	-	-
KYMERA THERAPEUTICS, INC.	9.34B	-	BBB	-	-
PRAXIS PRECISION MEDICINES, INC.	8.88B	-	B	-	-
ALKERMES PLC	9.1B		A
QIAGEN N.V.	8.29B		AAA
PROTAGONIST THERAPEUTICS, INC.	8.46B		BB		-
Average	18.07B		A
Weighted average by Cap.			A